An new study has found that sending text messages to heart attack survivors, encouraging them to make healthier lifestyle choices, can bring significant health benefits. EurActiv France reports.
Imagine a reality where surgeons practice difficult procedures on virtual renditions of their patients before walking into the operating room, and professional athletes review their exact muscle movements on a 3D game tape after they walk off the field.
Now that BioDigital, a 3D human body modeling startup, is releasing its API to the public, this is possible.
Over the past two years, the New York-based startup has worked closely with more than 100 organizations spanning all sectors of healthcare to tailor its virtual human body, comprising 7,000 objects modeled by hand, to specific use cases.
Melbourne-based startup CliniCloudis merging the Internet of Things and home healthcare to help doctors provide accurate diagnoses.
CliniCloud’s kit, which launched pre orders recently, includes a digital stethoscope and a non-contact thermometer, both of which are linked to a smartphone app. Users can then monitor and record readings taken, and show those readings to their doctors when they get the chance to see them.
El ministerio japonés de Sanidad, Trabajo y Bienestar ha autorizado la comercialización de Yondelis, antitumoral de origen marino desarrollado por la española Pharmamar (Zeltia), para el tratamiento de pacientes con sarcoma de tejidos blandos.
La autorización ha sido concedida a Taiho Pharmaceutical, socio japonés de Pharmamar, ha informado hoy a la Comisión Nacional del Mercado de Valores (CNMV) la farmacéutica, que ingresará unos 9 millones de euros.
Quirón Salud, participado en un 61% por el fondo británico CVC, seguiría así los pasos de otros grupos sanitarios en Europa, que se han desprendido de propiedades inmobiliarias al objeto de captar fondos con los que reforzar sus balances, informa Reuters.
El grupo hospitalario Quirón Salud analiza la posibilidad de poner a la venta parte de su cartera inmobiliaria, tal como ha reconocido un portavoz de la compañía a la agencia Reuters: "Es una operación que estamos estudiando".
There have been more than 400 healthcare deals in the first half of 2015, and the year is on track for a five-year high in funding.
VC-backed healthcare companies in the US have seen a jump in financing, with more than $6B already invested in the first half of 2015 across more than 400 deals, putting this year on track to hit a 5-year funding high.
n a mass-casualty situation, first responders often have to monitor dozens of injured people at once, to make sure information about each patient’s vitals is readily available. Previously, medics would have to take measurements repeatedly — a hugely time-consuming manual task that prevented them from administering emergency care. Now, the First Response Monitor, created by Cambridge Design Partnership, is a wearable device that can take over the task, monitoring patients’ heart rate and respiratory rate, providing medics with data on-demand.
Nanoparticles disguised as platelets, cells that circulate in the blood and form clots to stop bleeding from injured vessels, could serve as potent antibiotic treatments against certain hard-to-treat bacterial infections, according to new research.
In this recent boom of biotech IPOs, many startups have enlisted crossover investors—institutions that back both public and private companies—early in their lifecycle. It’s been a different story for Deciphera Pharmaceuticals, whose 12-year history includes moves from Massachusetts to Kansas and back. But regardless of the road it’s taken, Deciphera now finds itself joining the ranks of biotechs that are eyeing a trip to the public markets.
